Cargando…
Longer-Term Omega-3 LCPUFA More Effective Adjunct Therapy for Tuberculosis Than Ibuprofen in a C3HeB/FeJ Tuberculosis Mouse Model
Advancement in the understanding of inflammation regulation during tuberculosis (TB) treatment has led to novel therapeutic approaches being proposed. The use of immune mediators like anti-inflammatory and pro-resolving molecules for such, merits attention. Drug repurposing is a widely used strategy...
Autores principales: | Hayford, Frank E. A., Ozturk, Mumin, Dolman, Robin C., Blaauw, Renee, Nienaber, Arista, Loots, Du Toit, Brombacher, Frank, Smuts, Cornelius M., Parihar, Suraj P., Malan, Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113969/ https://www.ncbi.nlm.nih.gov/pubmed/33995381 http://dx.doi.org/10.3389/fimmu.2021.659943 |
Ejemplares similares
-
Adjunct n-3 Long-Chain Polyunsaturated Fatty Acid Treatment in Tuberculosis Reduces Inflammation and Improves Anemia of Infection More in C3HeB/FeJ Mice With Low n-3 Fatty Acid Status Than Sufficient n-3 Fatty Acid Status
por: Hayford, Frank E. A., et al.
Publicado: (2021) -
Omega-3 Fatty Acid and Iron Supplementation Alone, but Not in Combination, Lower Inflammation and Anemia of Infection in Mycobacterium tuberculosis-Infected Mice
por: Nienaber, Arista, et al.
Publicado: (2020) -
The effects of anti-inflammatory agents as host-directed adjunct treatment of tuberculosis in humans: a systematic review and meta-analysis
por: Hayford, Frank Ekow Atta, et al.
Publicado: (2020) -
In-Vivo Gene Signatures of Mycobacterium tuberculosis in C3HeB/FeJ Mice
por: Gautam, Uma Shankar, et al.
Publicado: (2015) -
Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis
por: Lanoix, Jean-Philippe, et al.
Publicado: (2015)